trending Market Intelligence /marketintelligence/en/news-insights/trending/mv0rjj5om3jx-gptg73eva2 content esgSubNav
In This List

Spero names replacement for outgoing director

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Spero names replacement for outgoing director

Spero Therapeutics Inc., a clinical-stage biopharmaceutical company based in Cambridge, Mass., named John Pottage Jr. to its board.

Pottage is filling the position of outgoing director Casper Breum on the board of the company, which develops and commercializes treatments for multidrug-resistant bacterial infections.

Pottage is currently serving as senior vice president and chief scientific and medical officer of ViiV Healthcare UK Ltd.